A pharmaceutical composition comprising n-[2-(2,1,3- benzothiadiazol-5-ylamino)-6 (2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-7-yl]-n'-(1,1-dimethylethyl-urea
PK140911AUndetermined Publication Date: 2010-09-23SANOFI AVENTIS SA
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200701537
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-09-23
Abstract
The object of the invention is a pharmaceutical composition comprising a compound N-[2(2,1,3-benzothiadiazol-5 ylamino)-6-(2,6-dithlorophenyl)pyrido[2,3-d]pyrimidin-7 yl]-N'-(1,1-dimethylethyl)-urea or a hydrate, a salt or a solvate thereof, for the treatment of leukaemias, in particular myeloid leukaemias.
Need to check novelty before this filing date? Find Prior Art